Amerisourcebergen Corp (ABC) 86.55 $ABC Temple

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Amerisourcebergen Corp (ABC) 86.55 $ABC

Temple University's Institute for Business and Information Technology names AmerisourceBergen CIO its Executive In Residence
PR Newswire - Wed Mar 30, 10:07AM CDT
Temple University's Institute for Business and Information Technology (IBIT) has appointed AmerisourceBergen Senior Vice President and Chief Information Officer Dale Danilewitz its newest Executive in Residence.
ABC: 86.55 (-0.54)

Walgreens Buys AmerisourceBergen Shares per Warrants
Zacks Equity Research - Zacks Investment Research - Mon Mar 21, 4:24PM CDT
Walgreens Boots Alliance, Inc. (WBA) announced that it has exercised warrants to purchase 22.7 million shares of AmerisourceBergen Corp. (ABC) for approximately $1.17 billion.
ABC: 86.55 (-0.54), WBA: 84.24 (+0.61), ARQL: 1.60 (+0.02), CORT: 4.68 (+0.41)

Walgreens spends nearly $1.2 B on AmerisourceBergen shares
By The Associated Press - AP - Fri Mar 18, 11:06AM CDT
Walgreens is spending nearly $1.2 billion to build its stake in AmerisourceBergen, the pharmaceutical wholesaler that supplies its drugstores, mail order and specialty pharmaceutical businesses.
ABC: 86.55 (-0.54), WBA: 84.24 (+0.61), RAD: 8.15 (+0.04)

Walgreens Boots Alliance Exercises Warrants to Purchase AmerisourceBergen Shares
BusinessWire - Fri Mar 18, 9:13AM CDT
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that it has exercised warrants to purchase 22,696,912 shares of AmerisourceBergen Corporation (NYSE: ABC) common stock for an aggregate payment of approximately $1.17 billion. The transaction was funded using existing cash on hand.
ABC: 86.55 (-0.54), WBA: 84.24 (+0.61)

AmerisourceBergen (ABC) Stock Started With ‘Outperform’ Rating at Credit Suisse
at The Street - Wed Mar 16, 3:04PM CDT
AmerisourceBergen (ABC) stock coverage was initiated with an ‘outperform’ rating and $103 price target at Credit Suisse.
ABC: 86.55 (-0.54)

These 5 Companies Will Probably Increase Their Dividends This Year
at The Street - Thu Mar 10, 6:32AM CST
2016 has been a bit of a wild ride for the market thus far, leaving plenty of investors on the hunt for deals -- and, in many cases, dividends.
ABC: 86.55 (-0.54), NKE: 61.47 (-0.57), EXPD: 48.81 (+0.10), SYK: 107.29 (+0.24), EQR: 75.03 (+0.18)

AmerisourceBergen Announces Results of Annual Meeting of Stockholders
BusinessWire - Thu Mar 03, 3:05PM CST
--Jane E. Henney, M.D. Appointed Lead Independent Director
ABC: 86.55 (-0.54)

AmerisourceBergen Rises 1.00% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Feb 10, 5:02PM CST
AmerisourceBergen (NYSE:ABC) traded in a range yesterday that spanned from a low of $85.22 to a high of $86.35. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $86.13 on volume of 2.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABC: 86.55 (-0.54)

After Yesterday's Rally of 1.00% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Feb 10, 5:01PM CST
AmerisourceBergen (NYSE:ABC) traded in a range yesterday that spanned from a low of $85.22 to a high of $86.35. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $86.13 on volume of 2.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABC: 86.55 (-0.54)

AmerisourceBergen to pay USD0.34 per share dividend
M2 - Wed Feb 10, 5:16AM CST
The board of directors of AmerisourceBergen Corporation (NYSE:ABC) on Tuesday declared a quarterly dividend of USD0.34 per share of the company's common stock.
ABC: 86.55 (-0.54)

PharMEDium Announces Sole Source Agreement with Premier, Inc.
BusinessWire - Tue Feb 09, 9:05AM CST
PharMEDium Services, LLC, a part of AmerisourceBergen, announced the renewal of its sole source group purchasing agreement with Premier, Inc. to continue providing outsourced pharmacy compounding and admixture services to Premier member facilities through December 2018. This agreement includes a wide range of services used for pain management, operating room anesthesia, intensive care, nerve block and labor and delivery.
ABC: 86.55 (-0.54)

AmerisourceBergen Declares Quarterly Dividend
BusinessWire - Tue Feb 09, 5:45AM CST
The Board of Directors of AmerisourceBergen Corporation (NYSE: ABC) today declared a quarterly dividend of $0.34 per common share, payable March 7, 2016, to stockholders of record at the close of business on February 22, 2016.
ABC: 86.55 (-0.54)

Downtrend Call Working As AmerisourceBergen Stock Falls 13.3% (ABC)
Comtex SmarTrend(R) - Fri Feb 05, 6:58PM CST
SmarTrend identified a Downtrend for AmerisourceBergen (NYSE:ABC) on January 8th, 2016 at $98.66. In approximately 4 weeks, AmerisourceBergen has returned 13.33% as of today's recent price of $85.50.
ABC: 86.55 (-0.54)

Momentum, Strategy within Today's Market - Analyst Notes on AmerisourceBergen, Xcel Energy, Shire and Syngenta
ACCESSWIRE - Fri Feb 05, 7:50AM CST
NEW YORK, NY / ACCESSWIRE / February 5, 2016 / Moments ago, Trader's Choice released new research updates concerning several developing situations, including one of the leading uptrends in today's market: XLI Technologies, Inc. (XLIT) - currently up 44.5% within the past 2 weeks.
XEL: 41.82 (+0.26), ABC: 86.55 (-0.54), SYT: 82.82 (-0.10), SHPG: 171.90 (+3.40)

SmarTrend Watching for Potential Rebound in Shares of AmerisourceBergen After 4.08% Loss
Comtex SmarTrend(R) - Thu Feb 04, 4:25PM CST
AmerisourceBergen (NYSE:ABC) traded in a range yesterday that spanned from a low of $80.50 to a high of $87.97. Yesterday, the shares fell 4.1%, which took the trading range below the 3-day low of $86.87 on volume of 8.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ABC: 86.55 (-0.54)

After Yesterday's Decline of 4.08%, AmerisourceBergen Offers Investors Better Value
Comtex SmarTrend(R) - Thu Feb 04, 4:25PM CST
AmerisourceBergen (NYSE:ABC) traded in a range yesterday that spanned from a low of $80.50 to a high of $87.97. Yesterday, the shares fell 4.1%, which took the trading range below the 3-day low of $86.87 on volume of 8.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ABC: 86.55 (-0.54)

AmerisourceBergen (ABC) Earnings Report: Q1 2016 Conference Call Transcript
at The Street - Thu Feb 04, 1:58PM CST
The following AmerisourceBergen (ABC) conference call took place on February 4, 2016, 11:00 AM ET. This is a transcript of that earnings call:
ABC: 86.55 (-0.54)

Tax gain lifts wholesaler AmerisourceBergen to 1Q profit
By LINDA A. JOHNSON - AP - Thu Feb 04, 1:29PM CST
TRENTON, N.J. (AP) — AmerisourceBergen Corp. swung to a profit in its fiscal first quarter, thanks to a huge income tax benefit. The medicine wholesaler reported a loss in the same period a year earlier. Its latest results beat Wall Street profit expectations but fell short on revenue.
ABC: 86.55 (-0.54)

Fitch: Publix, AmerisourceBergen Deal Underscores Power of Scale
BusinessWire - Thu Feb 04, 12:51PM CST
The largest drug sourcing entities and major U.S. drug distributors continue to prove the benefits of their unmatched scale as they win increasingly comprehensive distribution contracts with pharmacy chains in the U.S., according to Fitch Ratings. This trend is highlighted by Thursday's announced agreement between AmerisourceBergen (ABC) and Publix.
ABC: 86.55 (-0.54), OCR: 97.90 (-0.02)

AmerisourceBergen (ABC) Stock Drops on Lower Outlook
at The Street - Thu Feb 04, 11:48AM CST
AmerisourceBergen (ABC) stock is declining in early afternoon trading on Thursday after the company lowered its 2016 earnings guidance.
ABC: 86.55 (-0.54)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 234

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 178

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Photocure Navigates AssureMDx's Medicare Journey

Updated Category News Views 70

Aiming High with AssureMDx Photocure's got this bladder cancer test called AssureMDx that's at the center of its recent moves after acquiring Vesica Health a few months back. This isn't just any test; it's a urine-based, non-invasive way to snag an early look at bladder cancer. With the FDA's Breakthrough Device tag pinned on, they're not just dipping their toes in—this...

Continue Reading
Valmet Expands Board Maker Deal in Asia With New Line

Updated Category News Views 115

If there's one thing Valmet understands, it's the beauty of a longstanding business relationship. On November 9, 2026, the Finnish powerhouse announced another feather in its cap—a new board making line order from a major client in Asia. This deal ain't just another tick in the order books. No, sir, it's about prowess and power in the paper game. Building on Existing...

Continue Reading
Strathcona Resources Q3 2026: Dividends, Deals, and Growth

Updated Category News Views 202

Digging into Strathcona's Third Quarter Strathcona Resources (TSX: SCR) is strutting its stuff again, dropping a third-quarter report that reads like a playbook for solid energy sector performance. First off, let’s talk about that dividend bump. The company decided to sprinkle some cheer with a 7% increase in its quarterly dividend, now at $0.32 per share. Not exactly...

Continue Reading
Telespazio & Rivada Forge Secure Satellite Network

Updated Category News Views 0

Rivada's Outernet: A New Era of Connectivity Forget the terrestrial wires; we're talking about 600 satellites playing a space-age game of telephone. That's Rivada's Outernet for you, an orbital mesh network that's about to upend the very nature of global communications. Telespazio's new partnership with Rivada is like strapping a rocket onto secure connectivity in the...

Continue Reading
Korean 'Glocal' Districts Entice U.S. Tourists with Local Flavor

Updated Category News Views 97

Gwangju's Dongmyeong-dong is like the neighborhood artists and hipsters flock to in New York—except it’s got a Korean twist. Nestled in the Jeonnam region, this place is hot on American tourists' radar for its spicy mix of local culture, unique eats, and shops that scream individuality. It's becoming a magnet for folks who want to get a taste of Korean life but with a...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 172

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
SpaceMap Tackles Space Traffic With AI Innovation

Updated Category News Views 0

SpaceMap Takes Aim at the Crowded Space Above You ever look up and wonder what's hurtling above our noggins? More satellites than you can shake a stick at, that's what. And don't even start me on the debris floating around. This ain't just rocket science anymore; it's a crowded dance floor, and someone's gotta manage it. Enter SpaceMap, a plucky South Korean startup that...

Continue Reading
UAE Pioneers eATA Carnet System Beyond Europe

Updated Category News Views 56

Breaking Tradition with Digital Innovation Well, who would’ve thought? The UAE just leapt ahead in the trade game, becoming the first to roll out the eATA Carnet system beyond the cozy confines of Europe. This isn’t some run-of-the-mill tech rollout, folks. It’s a digital revolution in how temporary imports are handled—goodbye paper, hello efficiency! With this...

Continue Reading

Top 5 Most Recently Viewed Articles

Westgold Resources Initiates Mining Operations at South Junction

Updated Category News Views 110

Westgold Resources Launches Mining Operations at South Junction Westgold Resources Limited (ASX: WGX, OTCQX: WGXRF) has officially kicked off mining activities at the South Junction Lode, which is part of its Bluebird-South Junction mining complex located in Meekatharra. This marks an important milestone for the company as it aims to boost production in this crucial area....

Continue Reading
Inspira Apartments: A Florida Gem hits the Market

Updated Category News Views 37

Spotlight on Inspira Apartments in Naples Alright folks, Naples isn't just about sunshine and retirees lounging in their flip-flops. A real estate ripper-known as JBM® just threw the Inspira Apartments into the investment ring, with a Call For Offers set for July 30th, 2026. This isn’t your average cookie-cutter deal; it’s a top-tier, institutional-grade gem with 304...

Continue Reading
TechSee Welcomes Domenico D'Ambrosio to Advisory Board to Enhance AI Strategy

Updated Category News Views 233

TechSee Strengthens Advisory Board with Key Appointment TechSee, a household name in the telecom and technology landscape, is taking a significant step towards redefining customer experiences by welcoming Domenico D'Ambrosio to its Advisory Board. This strategic move aims to enhance the direction of the company as it ventures deeper into the world of Agentic AI, a...

Continue Reading
Human Longevity, Inc. Launches Advanced Pancreatic Cancer Test

Updated Category News Views 256

Human Longevity, Inc. Launches Advanced Pancreatic Cancer Test Human Longevity, Inc. (HLI), a frontrunner in the field of precision health, has recently enhanced its cancer prevention offerings. The company has introduced the ClearNote Health Avantect Pancreatic Cancer Test into its portfolio, designed to assist clients in detecting pancreatic cancer in its early stages....

Continue Reading
Idorsia Moves Forward After Ending Aprocitentan Exclusivity Deal

Updated Category News Views 408

Idorsia Announces Conclusion of Aprocitentan Exclusivity Agreement Idorsia Ltd has recently made a significant announcement regarding their drug, aprocitentan. The exclusivity agreement that was in place since November 2024 with an undisclosed partner has come to an end. This development was confirmed as the prospective partner chose not to finalize the deal, which...

Continue Reading